MAPT and Alzheimer disease: The results indicated that CSF neuroinflammatory biomarkers, including sTNFR1, sTNFR2, TGF-β1, ICAM1 and VCAM1, had positive correlations with CSF AD biomarkers (Aβ42, p-tau, and t-tau, Figure 2), even after FDR correction (Supplementary Table 2 in Supplementary Material 1).